Capital Impact Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,726
Closed -$995K 83
2024
Q1
$995K Sell
3,726
-1,266
-25% -$338K 1.29% 26
2023
Q4
$1.16M Buy
4,992
+2,853
+133% +$660K 1.52% 15
2023
Q3
$312K Hold
2,139
0.52% 78
2023
Q2
$494K Sell
2,139
-753
-26% -$174K 0.54% 87
2023
Q1
$701K Buy
2,892
+438
+18% +$106K 0.86% 31
2022
Q4
$712K Sell
2,454
-5,708
-70% -$1.66M 0.7% 43
2022
Q3
$570K Hold
8,162
0.57% 61
2022
Q2
$584K Sell
8,162
-4,394
-35% -$314K 0.54% 70
2022
Q1
$1.23M Sell
12,556
-5,693
-31% -$559K 0.9% 15
2021
Q4
$1.55M Buy
18,249
+6,474
+55% +$548K 1.07% 34
2021
Q3
$940K Hold
11,775
0.37% 103
2021
Q2
$1.15M Sell
11,775
-21,273
-64% -$2.07M 0.37% 99
2021
Q1
$3.87M Buy
33,048
+8,697
+36% +$1.02M 1.35% 25
2020
Q4
$2.71M Buy
+24,351
New +$2.71M 0.66% 65
2020
Q3
Sell
-24,351
Closed -$2.76M 122
2020
Q2
$2.76M Hold
24,351
0.92% 39
2020
Q1
$1.63M Buy
24,351
+996
+4% +$66.5K 0.68% 68
2019
Q4
$2.13M Buy
23,355
+2,762
+13% +$252K 0.75% 68
2019
Q3
$1.75M Buy
20,593
+2,445
+13% +$208K 0.67% 94
2019
Q2
$1.82M Buy
18,148
+4,489
+33% +$451K 0.67% 74
2019
Q1
$1.43M Hold
13,659
0.63% 90
2018
Q4
$1.43M Buy
13,659
+6,458
+90% +$675K 0.61% 93
2018
Q3
$1.53M Buy
7,201
+596
+9% +$127K 0.52% 103
2018
Q2
$1.84M Sell
6,605
-4,590
-41% -$1.28M 0.68% 62
2018
Q1
$1.31M Buy
+11,195
New +$1.31M 0.54% 101
2015
Q1
Sell
-1,080
Closed -$100K 287
2014
Q4
$100K Hold
1,080
0.05% 205
2014
Q3
$114 Hold
1,080
﹤0.01% 203
2014
Q2
$155K Buy
+1,080
New +$155K 0.12% 187